RMD
ResMed Inc.
Set alert
229.94 USD -22.89 -9.05%
228.54 Day range 248.05
182.82 52-week range 275.96
- YTD
- -4.54%
- 1 year
- -8.85%
- Open
- 246.56
- Prev close
- 252.83
- Mkt cap
- 32.34B
- Vol
- 3.47M
- Avg vol
- 1.32M
- EPS
- 10.43
- P/E
- 22.05
- Div yield
- 1.04%
More statistics
- Low
- 228.54
- High
- 248.05
- Forward P/E
- 17.34
- Beta
- 0.75
- Short ratio
- 10.34
- Inst. own
- 73.30%
- Dividend
- 2.64
- Ex-div date
- Aug 19, 2026
- Earnings
- Jan 28, 2027
- 50-d avg
- 231.77
- 200-d avg
- 225.03
- 1y target
- 251.52
Financial health
Altman Z-Score
11.69 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 3
- P/E 3
- P/B 2
Valuation
P/E 18.7×
FY 2017 5y median 27.0× FY 2026
P/S 5.0×
FY 2017 5y median 7.4× FY 2026
P/B 4.3×
FY 2017 5y median 6.3× FY 2026
P/FCF 17.1×
FY 2017 5y median 22.8× FY 2026
EV/EBITDA 12.8×
FY 2017 5y median 19.6× FY 2026
EV/Sales 4.9×
FY 2017 5y median 7.3× FY 2026
FCF Yield 5.8%
FY 2017 5y median 4.4% FY 2026
Profitability
Gross Margin 61.1%
FY 2017 5y median 56.7% FY 2026
Operating Margin 33.8%
FY 2017 5y median 28.2% FY 2026
Net Margin 26.9%
FY 2017 5y median 21.8% FY 2026
ROE 23.1%
FY 2017 5y median 23.1% FY 2026
ROIC 19.3%
FY 2017 5y median 18.3% FY 2026
ROA 17.0%
FY 2017 5y median 15.3% FY 2026
Growth (YoY)
Revenue 9.9%
FY 2017 FY 2026
Operating Income 13.2%
FY 2017 FY 2026
EPS (diluted) 9.4%
FY 2017 FY 2026
Free Cash Flow -0.7%
FY 2017 FY 2026
Financial Health
Current Ratio 3.1×
FY 2017 5y median 3.1× FY 2026
Quick Ratio 2.4×
FY 2017 5y median 1.8× FY 2026
Debt / Equity 0.1×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA -0.3×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 28.9× FY 2026
Dividends
Dividend Yield 1.2%
FY 2017 5y median 0.8% FY 2026
Payout Ratio 23.0%
FY 2017 5y median 27.7% FY 2026
Annual · latest fiscal year ends 2026-06-30